PetIQ

PetIQ

Vertical-integrated veterinary products and services

Overview

PetIQ provides a full suite of affordable pet care by owning the development, manufacturing, packaging, and distribution of veterinary products, along with operating veterinary clinics and wellness centers. Its products include flea and tick treatments, health and wellness items, prescription drugs, and pet treats, which are sold through its own channels to owners, clinics, and retailers. The company distinguishes itself by controlling the entire supply chain in-house, enabling consistent quality and lower costs, while combining product delivery with direct veterinary services. PetIQ aims to make high-quality pet care more accessible and affordable and to grow as a leading integrated provider in the veterinary market.

About PetIQ

Simplify's Rating
Why PetIQ is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Industrial & Manufacturing

Healthcare

Consumer Goods

Company Size

501-1,000

Company Stage

IPO

Headquarters

Eagle, Idaho

Founded

2010

Get referred to PetIQ

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • PetIQ closed the MYOS acquisition on July 29, 2026, broadening wellness cross-sell opportunities.
  • Bansk's ownership and the 2024 take-private remove quarterly pressure and support portfolio reshaping.
  • Minties FreshBites campaigns are driving retailer exposure across Walmart, Petco, Amazon, and Chewy.

What critics are saying

  • NAD ordered PetIQ on July 16, 2026 to drop unsupported #1 claims.
  • Elanco weaponized advertising scrutiny, and repeated challenges erode PetIQ's credibility with retailers.
  • After selling VIP Petcare to Tractor Supply on May 28, 2026, PetIQ lost services diversification.

What makes PetIQ unique

  • PetIQ combines branded pet health products with manufacturing, distribution, and retail reach.
  • Its portfolio includes PetArmor, Capstar, Minties, VetIQ, Rocco & Roxie, and MYOS.
  • The MYOS deal, closed July 29, 2026, adds clinically studied Fortetropin muscle-health products.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$1.5B

Above

Industry Average

Funded Over

1 Rounds

Buyout funding comparison data is currently unavailable. We're working to provide this information soon!
Buyout Funding Comparison
Coming Soon

Stock Price

Growth & Insights and Company News

Headcount

6 month growth

5%

1 year growth

4%

2 year growth

15%
VetPulse
Aug 1st, 2026
Vet industry intel: Jul 26 - Aug 1, 2026.

Vet industry intel: Jul 26 - Aug 1, 2026. High-signal veterinary industry stories triangulated from multiple sources, scored for relevance, and grouped by event type. Acquisitions & M&A (2) Regulatory & Policy (4) Products & Technology (6) Acquisitions & M&A. Jul 29, 2026 [9/10] prnewswire_vet PetIQ acquired MYOS, expanding its portfolio with a clinically-studied line of muscle health and wellness products for pets. PetIQ · MYOS | ID Jul 28, 2026 [9/10] dvm360 Bond Vet and Small Door Veterinary have merged to create a combined network of 55 veterinary clinics. Bond Vet · Small Door Veterinary · DVM360 Regulatory & Policy. Jul 28, 2026 [9/10] gnews_pe The FTC has launched an investigation into veterinary industry consolidation and its impact on rising pet care costs. Jul 31, 2026 [9/10] prnewswire_vet American Regent, Inc. Animal Health issued a nationwide recall for specific lots of Adequan Canine and Adequan i.m. injections after discovering visible glass fiber material in the products. American Regent, Inc. NY Aug 1, 2026 [9/10] vpn Four lots of Adequan injectable joint medications for dogs and horses are being recalled nationwide due to the potential presence of glass fibers. Jul 28, 2026 [9/10] businesswire_vet The FTC is investigating veterinary consolidation and its impact on rising pet healthcare costs. Products & Technology. Jul 29, 2026 [7/10] fda_cvm Splash Beverage Group is expanding its CannEpil platform into veterinary therapeutics by establishing a second FDA-regulated pharmaceutical development program. Splash Beverage Group Jul 29, 2026 [7/10] fda_cvm Splash Beverage Group is expanding its CannEpil platform into veterinary therapeutics to establish a second FDA-regulated pharmaceutical development program. Splash Beverage Group Jul 28, 2026 [7/10] businesswire_vet Arkansas State University's new College of Veterinary Medicine is officially opening and welcoming its inaugural class after years of planning. Arkansas State University | AR Jul 30, 2026 [7/10] businesswire_vet Arkansas State University has officially opened its new College of Veterinary Medicine, expanding veterinary education infrastructure in the state. Arkansas State University | AR Jul 31, 2026 [7/10] businesswire_vet Zoetis has received approval from the Veterinary Medicines Directorate (VMD) for its cat pain therapy, Portela. Zoetis · Vet Times Jul 30, 2026 [7/10] gnews_thrive Thrive Pet Healthcare has expanded pet insurance access for its clients through partnerships with Pumpkin and Trupanion to help manage veterinary care costs. Thrive Pet Healthcare · Pumpkin · Trupanion Most-mentioned this week PetIQ (1) · Bond Vet (1) · Small Door Veterinary (1) · Arkansas State University (1) · Thrive Pet Healthcare (1)

PR Newswire
Jul 29th, 2026
PetIQ acquires MYOS and its patented Fortetropin muscle health products for pets

PetIQ has acquired MYOS Corp, adding the muscle health brand and its patented Fortetropin ingredient to its pet health portfolio. Financial terms were not disclosed. MYOS develops clinically-studied muscle health products for pets, including dogs, cats, and horses. Its proprietary Fortetropin compound supports muscle growth and preservation by modulating myostatin, helping with mobility, injury recovery, and age-related muscle loss. The ingredient is backed by over a dozen clinical studies. The acquisition strengthens PetIQ's position in the pet health and wellness category. The company, owned by private investment firm Bansk Group, manufactures and distributes brands including PetArmor, Capstar, and Minties. MYOS products will continue to be marketed under their existing brand names. Lincoln International advised PetIQ, whilst Class VI Partners advised MYOS on the transaction.

EIN Presswire
Jul 26th, 2026
Dog Breath gets a Mintervention from Minties FreshBites.

Dog Breath gets a Mintervention from Minties FreshBites. July 26, 2026, 09:35 GMT New stage of campaign includes commercials and an activation for dog owners. Dog Breath Is Over made headlines. Minterventions makes housecalls." - Tom Christmann NEW YORK, NY, UNITED STATES, July 26, 2026 / EINPresswire.com / - Minties (R) is taking on dog breath again. And this time, it's personal. Back in November, Minties boldly declared "Dog Breath Is Over" in a newsbreak-style ad that introduced Minties FreshBites(TM)- a line of innovative, chewy dog dental treats with that can be offered throughout the day for a long-lasting chew, so nothing gets between you and your dog in your closest moments. America responded by buying new Minties FreshBites by the millions, exceeding the brand's most optimistic forecasts. So Minties and independent creative agency TiNY (the team behind the Dog Breath Is Over campaign) are following up on this story. And this time, it's personal. Did we say that already? "Dog Breath Is Over was the big message," said Jissan Cherian, PetIQ's Chief Marketing Officer. "Minterventions makes the message personal. If you've got a dog with stinky breath, we want to hear from you at minterventions.com ." TiNY shot two new spots for the Minterventions phase of the campaign. The first, "Cabbage", is airing this fall during live sports and features a dog named Mollie and an extendable hand. Why the extendable hand? "Mollie's breath smells like she ate a skunk (who also has bad breath).". A voiceover then asks the question at the center of the campaign: "Does your dog need a Mintervention?" Minties FreshBites is the answer, of course. A second spot called "Dumpster", featuring a dog who has been banished to the backyard, will run later in the year. Both spots were directed by Evan Silver of Reform School and edited by Tina Mintus out of Northern Lights in New York City. "It starts with a real, relatable problem," said Mike Rovner, TiNY partner and Chief Creative Officer. "That's the TiNY way - we help clients build worlds they can live in. Once you set up the rules of the world, you can have a lot of fun." Fun like inviting dog owners to submit their own stinky stories. Starting this month, pet parents can head to Minterventions.com to tell the internet exactly how bad it's gotten, in exchange for a free Mintervention Fresh Breath Kit to help them stage a Mintervention of their own. Minties is also bringing the Mintervention to the streets - literally. On Saturday, July 25, 2026, from 10 a.m. to 6 p.m., the brand will host a live Mintervention pop-up in Washington Square Park, where New Yorkers can bring their most malodorous mutts for a professional, in-person Mintervention. "We got a huge bump in awareness out of Dog Breath Is Over," said Michael Stoopack, TiNY partner and President. "Now we get real stories of dog breath being conquered one pet at a time. It's going to add so much context to the story." "We stand by our record," said Tom Christmann, TiNY partner and CMO. "Dog Breath Is Over made headlines. Minterventions makes house calls." Think your dog needs a Mintervention? Submit your story at Minterventions.com, or bring them to Washington Square Park on July 25. Minties FreshBites are available now on Walmart, Petco, Amazon, Chewy and more. Media Contact: Tom Christmann, Chief Marketing Officer, TiNY, [email protected], 646-441-7165. About PetIQ: PetIQ, LLC is a leading pet health and wellness company that develops, manufactures, and distributes branded over-the-counter medications and wellness products for pets, including PetArmor (R), Capstar (R), Nexstar (R), Minties (R), VetIQ (R), Rocco & Roxie (R), and Pur Luv (R). PetIQ's products are available to pet parents through retail and e-commerce channels at more than 60,000 points of distribution nationwide. Learn more at PetIQ.com. About TiNY: TiNY is an independent creative company built to make great work for great people - and have a great time doing it. Lean, nimble, and relentlessly idea-focused, TiNY partners with ambitious brands to make award-winning work for American Century Investments, AMP Awards, Avantis Investors, Ross University School of Medicine, and PetIQ. The three TiNY partners bring a century of combined experience running brands like Pepsi, Budweiser, E-Trade, Mercedes, NBA, Subway, and HSBC. Learn more at tinyadagency.com. Tom Christmann TiNY +1 646-441-7165 email us here Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above. You just read: July 26, 2026, 09:35 GMT EIN Presswire's priority is author transparency. We do our best to weed out false and misleading content. The content above is the sole responsibility of the author who makes it available. If you have any complaints, kindly contact the author above. Tom Christmann +1 646-441-7165

US National Times
Jul 26th, 2026
Dog Breath gets a Mintervention from Minties FreshBites.

Dog Breath gets a Mintervention from Minties FreshBites. New stage of campaign includes commercials and an activation for dog owners. Dog Breath Is Over made headlines. Minterventions makes housecalls." - Tom Christmann NEW YORK, NY, UNITED STATES, July 26, 2026 / EINPresswire.com / - Minties (R) is taking on dog breath again. And this time, it's personal. Back in November, Minties boldly declared "Dog Breath Is Over" in a newsbreak-style ad that introduced Minties FreshBites(TM)- a line of innovative, chewy dog dental treats with that can be offered throughout the day for a long-lasting chew, so nothing gets between you and your dog in your closest moments. America responded by buying new Minties FreshBites by the millions, exceeding the brand's most optimistic forecasts. So Minties and independent creative agency TiNY (the team behind the Dog Breath Is Over campaign) are following up on this story. And this time, it's personal. Did US National Times say that already? "Dog Breath Is Over was the big message," said Jissan Cherian, PetIQ's Chief Marketing Officer. "Minterventions makes the message personal. If you've got a dog with stinky breath, we want to hear from you at minterventions.com ." TiNY shot two new spots for the Minterventions phase of the campaign. The first, "Cabbage", is airing this fall during live sports and features a dog named Mollie and an extendable hand. Why the extendable hand? "Mollie's breath smells like she ate a skunk (who also has bad breath).". A voiceover then asks the question at the center of the campaign: "Does your dog need a Mintervention?" Minties FreshBites is the answer, of course. A second spot called "Dumpster", featuring a dog who has been banished to the backyard, will run later in the year. Both spots were directed by Evan Silver of Reform School and edited by Tina Mintus out of Northern Lights in New York City. "It starts with a real, relatable problem," said Mike Rovner, TiNY partner and Chief Creative Officer. "That's the TiNY way - we help clients build worlds they can live in. Once you set up the rules of the world, you can have a lot of fun." Fun like inviting dog owners to submit their own stinky stories. Starting this month, pet parents can head to Minterventions.com to tell the internet exactly how bad it's gotten, in exchange for a free Mintervention Fresh Breath Kit to help them stage a Mintervention of their own. Minties is also bringing the Mintervention to the streets - literally. On Saturday, July 25, 2026, from 10 a.m. to 6 p.m., the brand will host a live Mintervention pop-up in Washington Square Park, where New Yorkers can bring their most malodorous mutts for a professional, in-person Mintervention. "We got a huge bump in awareness out of Dog Breath Is Over," said Michael Stoopack, TiNY partner and President. "Now we get real stories of dog breath being conquered one pet at a time. It's going to add so much context to the story." "We stand by our record," said Tom Christmann, TiNY partner and CMO. "Dog Breath Is Over made headlines. Minterventions makes house calls." Think your dog needs a Mintervention? Submit your story at Minterventions.com, or bring them to Washington Square Park on July 25. Minties FreshBites are available now on Walmart, Petco, Amazon, Chewy and more. Media Contact: Tom Christmann, Chief Marketing Officer, TiNY, [email protected], 646-441-7165. About PetIQ: PetIQ, LLC is a leading pet health and wellness company that develops, manufactures, and distributes branded over-the-counter medications and wellness products for pets, including PetArmor (R), Capstar (R), Nexstar (R), Minties (R), VetIQ (R), Rocco & Roxie (R), and Pur Luv (R). PetIQ's products are available to pet parents through retail and e-commerce channels at more than 60,000 points of distribution nationwide. Learn more at PetIQ.com. About TiNY: TiNY is an independent creative company built to make great work for great people - and have a great time doing it. Lean, nimble, and relentlessly idea-focused, TiNY partners with ambitious brands to make award-winning work for American Century Investments, AMP Awards, Avantis Investors, Ross University School of Medicine, and PetIQ. The three TiNY partners bring a century of combined experience running brands like Pepsi, Budweiser, E-Trade, Mercedes, NBA, Subway, and HSBC. Learn more at tinyadagency.com. Tom Christmann TiNY +1 646-441-7165 email US National Times here Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind. US National Times do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Africa Business Watch
Jul 16th, 2026
National Advertising Division finds certain PetIQ claims supported; recommends other comparative claims be modified or discontinued.

National Advertising Division finds certain PetIQ claims supported; recommends other comparative claims be modified or discontinued. New York, NY, July 16, 2026 (GLOBE NEWSWIRE) - Following a challenge brought by Elanco Animal Health Incorporated, BBB National Programs' National Advertising Division determined that PetIQ, LLC provided a reasonable basis for its vet-recommended active-ingredient claims for its PetArmor(R) Extend Flea & Tick Collar. However, the National Advertising Division (NAD) recommended that PetIQ modify or discontinue certain claims regarding market leadership, brand growth, consumer trust, comparative performance, and product attributes. PetIQ and Elanco compete in the market for pet flea-and-tick prevention products. Elanco markets Seresto and PetIQ markets PetArmor Extend, which each contain the active ingredients imidacloprid and flumethrin. Elanco challenged PetIQ's brand-superiority and vet-recommended ingredient claims for its PetArmor flea and tick lineup, including assertions that PetArmor Extend is made with the "#1 vet-recommended" active ingredients, alongside claims that PetIQ is the "#1 brand in total solutions" and the "#1 fastest-growing brand" in the category. NAD determined that PetIQ provided a reasonable basis for its vet-recommended active-ingredient claims, finding that PetIQ's survey evidence supported the message that veterinarians recommend the imidacloprid and flumethrin active-ingredient combination more than other flea-and-tick collar active-ingredient combinations. However, NAD determined that PetIQ did not provide adequate support for the broad market-leadership message conveyed by its "#1 Brand in Total Flea & Tick Solutions" claim or the unqualified growth message conveyed by its "#1 Fastest Growing Flea & Tick Brand" claim. Therefore, NAD recommended that the challenged "#1 Brand" and "#1 Fastest Growing" claims be discontinued or modified to avoid conveying unsupported market leadership and growth messages. Additionally, NAD recommended that PetIQ discontinue or modify its challenged "trusted by millions," duration, comparative performance, and product attribute claims to avoid conveying unsupported messages. In its advertiser statement, PetIQ stated it "agrees to comply with its decision." All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. Per NAD/NARB Procedures, this release may not be used for promotional purposes. About BBB National Programs: BBB National Programs, a non-profit organization, is the home of U.S. independent industry self-regulation, currently operating more than 20 globally recognized programs that have been helping enhance consumer trust in business for more than 50 years. These programs provide third-party accountability and dispute resolution services that address existing and emerging industry issues, create fair competition for businesses, and a better experience for consumers. BBB National Programs continues to evolve its work and grow its impact by providing business guidance and fostering best practices in advertising, child-and-teen-directed marketing, data privacy, dispute resolution, automobile warranty, technology, and emerging areas. To learn more, visit bbbprograms.org. About the National Advertising Division: The National Advertising Division (NAD) of BBB National Programs provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. NAD reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and creating fair competition for business. Name: Jennifer Rosenberg Email: [email protected] Job Title: Media Relations Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for PetIQ right now.

Find jobs on Simplify and start your career today

We update PetIQ's jobs every few hours, so check again soon! Browse all jobs →